JPMorgan pro's top health care picks | Mon, 21 Apr 2014 16:02:37 -0700

According to JPMorgan Chase's senior medical technology analyst Mike Weinstein, the pullback presents a perfect buying opportunity for select names in the space. On CNBC's "Fast Money" on Monday, Weinstein gave his top picks in health care that ...

View Complete Story

CEO Jamie Dimon Warns JPM Shareholders To Beware of Costly New Risks ...

Forbes | Sat, 12 Apr 2014 01:55:38 -0700

The latest must-read in financial circles is JPM boss Jamie Dimon's 32 page letter to JP Morgan Chase Chase shareholders made public last week. It is a mixture of gritty optimism going forward with rueful musings on the costly nature of regulation in ...


View Complete Story

JPMorgan Chase & Co. Rating Reiterated by Nomura (JPM)

WKRB News | Mon, 21 Apr 2014 06:07:30 -0700

JPMorgan Chase & Co. logo JPMorgan Chase & Co. (NYSE:JPM)'s stock had its “neutral” rating restated by research analysts at Nomura in a report released on Monday, Analyst Ratings reports. They currently have a $62.00 target price on the ...

View Complete Story

Morning Scan: More JPM Reshuffling; Is Square for Sale?

American Banker (subscription) | Mon, 21 Apr 2014 06:17:49 -0700

JPM Shuffle: Shao Zili, JPMorgan Chase's chairman and chief executive in China, will step down from those positions and take over as vice chairman of the Asia-Pacific region as soon as a replacement is found. The unofficial official word from the bank ...

View Complete Story